View in EDS HTML Full Text PDF Full Text

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.

Saved in:
Bibliographic Details
Title: Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.
Authors: Sun, Yan1,2 (AUTHOR), Yang, Haochen3 (AUTHOR), Xu, Qing4 (AUTHOR), Li, Xingya5 (AUTHOR), Lou, Jinxing1,2 (AUTHOR), Duan, Jianchun6 (AUTHOR), Xu, Jiachen6 (AUTHOR), Liu, Zhuqing4 (AUTHOR), Xia, Yong1,2 (AUTHOR), Lin, Zhicai1,2 (AUTHOR), Li, Linlin5 (AUTHOR), Sun, Dan2 (AUTHOR), Li, Jiaguo1,2 (AUTHOR), Liu, Tao2 (AUTHOR), Guo, Jun2 (AUTHOR), Xu, Wenfeng2 (AUTHOR), Zhu, Weimin2 (AUTHOR), Liu, Yi2 (AUTHOR), Sun, Boyang6 (AUTHOR), Zhong, Jia6 (AUTHOR)
Source: Advanced Science. 6/24/2026, Vol. 13 Issue 35, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202508754